160 related articles for article (PubMed ID: 29606178)
1. Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons.
Domínguez A; Romero-Tamarit A; Soldevila N; Godoy P; Jané M; Martínez A; Torner N; Caylà JA; Rius C;
Epidemiol Infect; 2018 May; 146(7):799-808. PubMed ID: 29606178
[TBL] [Abstract][Full Text] [Related]
2. Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Adlhoch C; Delgado-Sanz C; Carnahan A; Larrauri A; Popovici O; Bossuyt N; Thomas I; Kynčl J; Slezak P; Brytting M; Guiomar R; Redlberger-Fritz M; Maistre Melillo J; Melillo T; van Gageldonk-Lafeber AB; Marbus SD; O'Donnell J; Domegan L; Gomes Dias J; Olsen SJ
Euro Surveill; 2023 Jan; 28(4):. PubMed ID: 36700868
[TBL] [Abstract][Full Text] [Related]
3. Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010-2015).
Torner N; Martínez A; Basile L; Mosquera M; Antón A; Rius C; Sala MR; Minguell S; Plasencia E; Carol M; Godoy P; Follia N; Barrabeig I; Marcos MA; Pumarola T; Jané M
BMC Res Notes; 2018 Apr; 11(1):244. PubMed ID: 29655370
[TBL] [Abstract][Full Text] [Related]
4. Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.
Venkatesan S; Myles PR; Leonardi-Bee J; Muthuri SG; Al Masri M; Andrews N; Bantar C; Dubnov-Raz G; Gérardin P; Koay ESC; Loh TP; Memish Z; Miller E; Oliva ME; Rath BA; Schweiger B; Tang JW; Tran D; Vidmar T; Waight PA; Nguyen-Van-Tam JS
Clin Infect Dis; 2017 May; 64(10):1328-1334. PubMed ID: 28199524
[TBL] [Abstract][Full Text] [Related]
5. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.
Muthuri SG; Venkatesan S; Myles PR; Leonardi-Bee J; Lim WS; Al Mamun A; Anovadiya AP; Araújo WN; Azziz-Baumgartner E; Báez C; Bantar C; Barhoush MM; Bassetti M; Beovic B; Bingisser R; Bonmarin I; Borja-Aburto VH; Cao B; Carratala J; Cuezzo MR; Denholm JT; Dominguez SR; Duarte PA; Dubnov-Raz G; Echavarria M; Fanella S; Fraser J; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hoffmann M; Hu X; Islam QT; Jiménez MF; Kandeel A; Keijzers G; Khalili H; Khandaker G; Knight M; Kusznierz G; Kuzman I; Kwan AM; Lahlou Amine I; Langenegger E; Lankarani KB; Leo YS; Linko R; Liu P; Madanat F; Manabe T; Mayo-Montero E; McGeer A; Memish ZA; Metan G; Mikić D; Mohn KG; Moradi A; Nymadawa P; Ozbay B; Ozkan M; Parekh D; Paul M; Poeppl W; Polack FP; Rath BA; Rodríguez AH; Siqueira MM; Skręt-Magierło J; Talarek E; Tang JW; Torres A; Törün SH; Tran D; Uyeki TM; van Zwol A; Vaudry W; Velyvyte D; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS
Influenza Other Respir Viruses; 2016 May; 10(3):192-204. PubMed ID: 26602067
[TBL] [Abstract][Full Text] [Related]
6. Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season.
Soldevila N; Acosta L; Martínez A; Godoy P; Torner N; Rius C; Jané M; Domínguez A;
Sci Rep; 2021 Jun; 11(1):13587. PubMed ID: 34193898
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiviral treatment in older patients hospitalized with confirmed influenza.
Soldevila N; Toledo D; Ortiz de Lejarazu R; Tamames S; Castilla J; Astray J; Fernández MA; Martín V; Egurrola M; Morales Suárez-Varela M; Domínguez À;
Antiviral Res; 2020 Jun; 178():104785. PubMed ID: 32234540
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype.
Martínez A; Soldevila N; Romero-Tamarit A; Torner N; Godoy P; Rius C; Jané M; Domínguez À;
PLoS One; 2019; 14(1):e0210353. PubMed ID: 30633778
[TBL] [Abstract][Full Text] [Related]
9. Hospital-acquired influenza infections detected by a surveillance system over six seasons, from 2010/2011 to 2015/2016.
Godoy P; Torner N; Soldevila N; Rius C; Jane M; Martínez A; Caylà JA; Domínguez A;
BMC Infect Dis; 2020 Jan; 20(1):80. PubMed ID: 31992207
[TBL] [Abstract][Full Text] [Related]
10. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.
Zarychanski R; Stuart TL; Kumar A; Doucette S; Elliott L; Kettner J; Plummer F
CMAJ; 2010 Feb; 182(3):257-64. PubMed ID: 20093297
[TBL] [Abstract][Full Text] [Related]
11. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study.
Chen L; Han X; Li YL; Zhang C; Xing X
BMC Infect Dis; 2020 Aug; 20(1):628. PubMed ID: 32842994
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics of novel influenza A (H1N1) in antiviral drug users in Korea.
Choi K; Cho SI; Hashizume M; Kim H
PLoS One; 2012; 7(10):e47634. PubMed ID: 23082184
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
Venkatesan S; Myles PR; Bolton KJ; Muthuri SG; Al Khuwaitir T; Anovadiya AP; Azziz-Baumgartner E; Bajjou T; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Chinbayar T; Cilloniz C; Denholm JT; Dominguez SR; Duarte PAD; Dubnov-Raz G; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hu XY; Islam QT; Jiménez MF; Keijzers G; Khalili H; Kusznierz G; Kuzman I; Langenegger E; Lankarani KB; Leo YS; Libster RP; Linko R; Madanat F; Maltezos E; Mamun A; Manabe T; Metan G; Mickiene A; Mikić D; Mohn KGI; Oliva ME; Ozkan M; Parekh D; Paul M; Rath BA; Refaey S; Rodríguez AH; Sertogullarindan B; Skręt-Magierło J; Somer A; Talarek E; Tang JW; To K; Tran D; Uyeki TM; Vaudry W; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS
J Infect Dis; 2020 Jan; 221(3):356-366. PubMed ID: 31314899
[TBL] [Abstract][Full Text] [Related]
14. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
Kawai N; Ikematsu H; Kawashima T; Maeda T; Ukai H; Hirotsu N; Iwaki N; Kashiwagi S
Influenza Other Respir Viruses; 2013 May; 7(3):448-55. PubMed ID: 22897904
[TBL] [Abstract][Full Text] [Related]
15. Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain).
Acosta L; Soldevila N; Torner N; Martínez A; Ayneto X; Rius C; Jané M; Domínguez A; The Influenza Surveillance Network Of Catalonia Pidirac
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452337
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15.
Domínguez A; Soldevila N; Toledo D; Godoy P; Espejo E; Fernandez MA; Mayoral JM; Castilla J; Egurrola M; Tamames S; Astray J; Morales-Suárez-Varela M;
Euro Surveill; 2017 Aug; 22(34):. PubMed ID: 28857047
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of the hospitalized patients with 2009 pandemic influenza A (H1N1) in Santa Fe, Argentina.
Kusznierz G; Uboldi A; Sosa G; Torales S; Colombo J; Moyano C; Escobar H; Lejona S; Anchart E; Gómez A; Imaz S
Influenza Other Respir Viruses; 2013 May; 7(3):410-7. PubMed ID: 22817648
[TBL] [Abstract][Full Text] [Related]
18. Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.
Marin-Corral J; Climent C; Muñoz R; Samper M; Dot I; Vilà C; Masclans JR; Rodriguez A; Martin-Loeches I; Álvarez-Lerma F;
Med Intensiva (Engl Ed); 2018 Nov; 42(8):473-481. PubMed ID: 29559173
[TBL] [Abstract][Full Text] [Related]
19. Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study.
Chen L; Han X; Li Y; Zhang C; Xing X
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1231-1238. PubMed ID: 32026193
[TBL] [Abstract][Full Text] [Related]
20. Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada.
Coleman BL; Hassan K; Green K; Gubbay JB; Katz K; Mazzulli T; McNeil S; Muller M; Powis J; Richardson D; Simor A; ; McGeer AJ
Antiviral Res; 2017 Apr; 140():158-163. PubMed ID: 28179155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
